Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence
CA 2425563 A1 · Owner: Sakai, Kenji · Inventors: Kitagawa, Hisato; Sakai, Kenji; Muramatsu, Ikunobu
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to m-amino-phenylimino-imidazolidine derivatives with a novel substituent pattern on the phenyl ring of general formula (I) or of , general formula (II) wherein R1 is F, Cl, Br, CH2F, CF2H or CF3 R2 is NR6R7, R6 being Me, Et, Pr or iPr and R7 being Me Et or Pr; and R3, R4 and R5 are , each independently of each other, H, Me, F, Cl Br, CH2F, CF2H and/or CF3 and , if R4 is Me F, Cl, Br, CH2F, CF2H or CF3, then R1 is additionally also H or Me; and or their pharmacologically compatible salts to the use thereof for , producing medicaments especially for treating urinary incontinence and to a , method for producing the same.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 11, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 11, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 11, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.